OPEN END TURBO OPTIONSSCHEIN SHORT - RESMED | Real-time BOERSE MUENCHEN 09:57:15 31/05/2024 pm IST | ||
| 6.4 EUR | +3.56% |
|
| Current month | +4.04% | ||
| 1 month | +4.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 6.4 | +3.56% |
| 30/24/30 | 6.18 | -4.04% |
| 29/24/29 | 6.44 | +2.22% |
| 28/24/28 | 6.3 | +9.19% |
| 27/24/27 | 5.77 | -0.17% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 09:57 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Goldman Sachs |
| WKN | GX9KJB |
| ISIN | DE000GX9KJB3 |
| Date issued | 12/09/2022 |
| Strike | 275.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.71 € |
|---|---|
| Lowest since issue | 3.59 € |
| Spread | 0.02 € |
| Spread % | 0.31% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
209.3
USD
Average target price
216.6
USD
Spread / Average Target
+3.49%
- Stock Market
- Certificates
- Certificat
